Parasites and cancers: parasite antigens as possible targets for cancer immunotherapy

Anti-malaria drug blocks proteotoxic stress response: Anti-cancer implications

(2011) Nickolay Neznanov et al.   CELL CYCLE

Antitumor Effect of Malaria Parasite Infection in a Murine Lewis Lung Cancer Model through Induction of Innate and Adaptive Immunity

(2011) Lili Chen et al.   PLoS One

Inhibition of receptor tyrosine kinases restores immunocompetence and improves immune-dependent chemotherapy against experimental leishmaniasis in mice

(2010) Jane E. Dalton et al.   JOURNAL OF CLINICAL INVESTIGATION

Suppressed CD31 Expression in Sarcoma-180 Tumors after Injection with Toxoplasma gondii Lysate Antigen in BALB/c Mice

(2010) Kyoung-Ho Pyo et al.   KOREAN JOURNAL OF PARASITOLOGY

In Vitro Activity of Antifolate and Polymorphism in Dihydrofolate Reductase of Plasmodium falciparum Isolates from the Kenyan Coast: Emergence of Parasites with Ile-164-Leu Mutation

(2009) S. M. Kiara et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Effects of Toxoplasma gondii and Toxocara canis Antigens on WEHI-164 Fibrosarcoma Growth in a Mouse Model

(2009) Hossein Yousofi Darani et al.   KOREAN JOURNAL OF PARASITOLOGY

Helminths and malignancy

(2009) B. J. VENNERVALD et al.   PARASITE IMMUNOLOGY

The study of immunological component in antitumor effect of Trypanosoma cruzi

(2008) A. V. Zenina et al.   BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE

Gold complexes as potential anti-parasitic agents

(2008) Maribel Navarro   COORDINATION CHEMISTRY REVIEWS

A recombinant protein based on Trypanosoma cruzi surface molecule gp82 induces apoptotic cell death in melanoma cells

(2008) Vanessa D. Atayde et al.   MELANOMA RESEARCH

Suramin: Clinical Uses and Structure-Activity Relationships

(2008) Ross McGeary et al.   MINI-REVIEWS IN MEDICINAL CHEMISTRY